From December 7, 2023 to December 31, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for $0 million under the buyback announced on December 7, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
86.72 USD | -0.80% | +1.72% | +13.73% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.73% | 52.68B | |
+11.73% | 221B | |
+9.53% | 186B | |
+14.63% | 137B | |
+27.47% | 109B | |
-0.04% | 63.09B | |
+4.86% | 50.86B | |
+7.72% | 42.53B | |
+7.86% | 37.76B | |
+24.30% | 31.86B |
- Stock Market
- Equities
- EW Stock
- News Edwards Lifesciences Corporation
- Tranche Update on Edwards Lifesciences Corporation (NYSE: EW)'s Equity Buyback Plan announced on December 7, 2023.